Related Experiment Videos
Effectiveness of antiinfectives
Ramona McLoughlin1, Colm O'Morain
1Adelaide and Meath Hospital, and Trinity College, Dublin, Ireland.
Chemotherapy
|August 10, 2005
Summary
Helicobacter pylori eradication therapy faces challenges due to poor patient compliance and rising antibiotic resistance, impacting treatment effectiveness. These factors limit the success of standard first- and second-line treatments for this common infection.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Gastroenterology
Background:
- Helicobacter pylori infection is a widespread global health concern, leading to substantial illness and death.
- Persistent colonization by H. pylori contributes significantly to disease burden.
Purpose of the Study:
- To evaluate the effectiveness of current H. pylori eradication strategies.
- To identify key factors limiting treatment success.
Main Methods:
- Standard first-line therapy involves a 7-day course of a proton pump inhibitor (or ranitidine bismuth citrate) with amoxicillin and clarithromycin.
- Second-line therapy for treatment failures includes a proton pump inhibitor, bismuth, metronidazole, and tetracycline.
- Cost-effectiveness analysis guides the selection of these eradication regimens.
Main Results:
- The established treatment protocols are considered cost-effective.
- However, the overall effectiveness of these regimens is compromised.
Conclusions:
- Patient non-compliance with prescribed treatment durations is a major impediment to successful H. pylori eradication.
- Increasing antibiotic resistance among H. pylori strains further diminishes the efficacy of available antiinfective therapies.